Pten signaling in gliomas.

作者: Christiane B. Knobbe , Guido Reifenberger , Adrian Merlo

DOI: 10.1093/NEUONC/4.3.196

关键词:

摘要: In 1997, the PTEN gene (phosphatase and tensin homolog deleted on chromosome 10) was identified as a tumor suppressor long arm of 10. Since then, important progress has been made with respect to understanding role Pten protein in normal development brain well molecular pathogenesis human gliomas. This review summarizes current state art concerning involvement aberrant function different biologic features malignant gliomas, such loss cell-cycle control uncontrolled cell proliferation, escape from apoptosis, invasion, neoangiogenesis. Most tumor-suppressive properties are dependent its lipid phosphatase activity, which inhibits phosphatidylinositol-3'-kinase (PI3K)/Akt signaling pathway through dephosphorylation phosphatidylinositol-(3,4,5)-triphosphate. The additional dual-specificity may also play glioma pathogenesis. Besides wealth data elucidating functional roles Pten, recent studies suggest diagnostic significance alterations marker for poor prognosis anaplastic astrocytomas oligodendrogliomas. Furthermore, possibility selective targeting mutant cells by specific pharmacologic inhibitors members Pten/PI3K/Akt opens up new perspectives targeted therapy

参考文章(159)
Theo Goosen, Fons Debets, Molecular Genetic Analysis Fungal Genetics. pp. 97- 117 ,(2020) , 10.1201/9781003067436-5
Jürgen A. Kraus, Katrin Lamszus, Nicole Glesmann, Martina Beck, Marietta Wolter, Michael Sabel, Dietmar Krex, Thomas Klockgether, Guido Reifenberger, Uwe Schlegel, Molecular genetic alterations in glioblastomas with oligodendroglial component. Acta Neuropathologica. ,vol. 101, pp. 311- 320 ,(2001) , 10.1007/S004010000258
Andreas Gescher, Analogs of staurosporine: potential anticancer drugs? General Pharmacology-the Vascular System. ,vol. 31, pp. 721- 728 ,(1998) , 10.1016/S0306-3623(98)00069-X
Antonio D. Cristofano, Barbara Pesce, Carlos Cordon-Cardo, Pier P. Pandolfi, Pten is essential for embryonic development and tumour suppression. Nature Genetics. ,vol. 19, pp. 348- 355 ,(1998) , 10.1038/1235
Stéphanie A. Backman, Vuk Stambolic, Akira Suzuki, Jillian Haight, Andrew Elia, James Pretorius, Ming-Sound Tsao, Patrick Shannon, Brad Bolon, Gwen O. Ivy, Tak W. Mak, Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease. Nature Genetics. ,vol. 29, pp. 396- 403 ,(2001) , 10.1038/NG782
Binhua P. Zhou, Yong Liao, Weiya Xia, Yiyu Zou, Bill Spohn, Mien-Chie Hung, HER-2 / neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation Nature Cell Biology. ,vol. 3, pp. 973- 982 ,(2001) , 10.1038/NCB1101-973
Antonio Di Cristofano, Marika De Acetis, Andrew Koff, Carlos Cordon-Cardo, Pier P Pandolfi, Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse. Nature Genetics. ,vol. 27, pp. 222- 224 ,(2001) , 10.1038/84879
Paul Kaloudis, Kathrin H. Kirsch, Nikola P. Pavletich, Hidesaburo Hanafusa, Maria-Magdalena Georgescu, Haijuan Yang, Stabilization and Productive Positioning Roles of the C2 Domain of PTEN Tumor Suppressor Cancer Research. ,vol. 60, pp. 7033- 7038 ,(2000)
Weiya Xia, Bill Spohn, Mong-Hong Lee, Mien-Chie Hung, Binhua P. Zhou, Yong Liao, Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nature Cell Biology. ,vol. 3, pp. 245- 252 ,(2001) , 10.1038/35060032
Benjamin E. Alderete, C. David James, Robert B. Jenkins, Wanguo Liu, Lori Frederick, PTEN/MMAC1 Mutations and EGFR Amplification in Glioblastomas Cancer Research. ,vol. 57, pp. 5254- 5257 ,(1997)